31 July 2015
Thierry Le Hénaff,
Chairman and CEO of Arkema
DETAILS
• Adjusted net income of €1.65 per share, +51% up on 2Q’14
• Good cash flow generation
o +€105 million free cash flow (-€17 million in 2Q’14)
o €1,773 million net debt down compared to
end of March 2015 (€1,888 million)
• Marked improvement in EBITDA margin to 15.2% (13.8% in 2Q’14)
• Excellent rise in EBITDA to €320 million, 52% up
on 2Q’14 (€210 million)
o Significant increase of the EBITDA without Bostik, up by 28%
o Good and promising performance of Bostik for its start
within Arkema
o Solid contribution of new Thiochemicals plant in Malaysia
• Significant 39% increase of sales versus 2Q’14 at €2,106 million
including Bostik’s contribution of 27% and volumes up by 2.1%
VIEW ARKEMA SECOND QUARTER 2015 RESULTS
WWW.CHEMWINFO.COM BY KHUN PHICHAI